A new trading day began on Monday, with Fractyl Health Inc (NASDAQ: GUTS) stock price up 44.72% from the previous day of trading, before settling in for the closing price of $1.99. GUTS’s price has ranged from $0.87 to $6.57 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 7.82%. With a float of $20.88 million, this company’s outstanding shares have now reached $48.92 million.
In an organization with 107 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -323.33%, operating margin of -161246.67%, and the pretax margin is -148511.67%.
Fractyl Health Inc (GUTS) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Fractyl Health Inc is 57.37%, while institutional ownership is 33.03%. The most recent insider transaction that took place on Mar 14 ’25, was worth 22,980. In this transaction Director of this company bought 17,901 shares at a rate of $1.28, taking the stock ownership to the 17,901 shares. Before that another transaction happened on Mar 14 ’25, when Company’s Director bought 31,000 for $1.30, making the entire transaction worth $40,210. This insider now owns 31,000 shares in total.
Fractyl Health Inc (GUTS) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 7.82% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.56% during the next five years compared to -12.32% drop over the previous five years of trading.
Fractyl Health Inc (NASDAQ: GUTS) Trading Performance Indicators
Here are Fractyl Health Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.50. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2350.79.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.84, a number that is poised to hit -0.36 in the next quarter and is forecasted to reach -1.74 in one year’s time.
Technical Analysis of Fractyl Health Inc (GUTS)
Let’s dig in a bit further. During the last 5-days, its volume was 0.6 million. That was better than the volume of 0.3 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 81.46%. Additionally, its Average True Range was 0.21.
During the past 100 days, Fractyl Health Inc’s (GUTS) raw stochastic average was set at 93.05%, which indicates a significant increase from 89.05% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 168.67% in the past 14 days, which was higher than the 113.31% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5200, while its 200-day Moving Average is $2.0100. However, in the short run, Fractyl Health Inc’s stock first resistance to watch stands at $3.2700. Second resistance stands at $3.6600. The third major resistance level sits at $4.2900. If the price goes on to break the first support level at $2.2500, it is likely to go to the next support level at $1.6200. Assuming the price breaks the second support level, the third support level stands at $1.2300.
Fractyl Health Inc (NASDAQ: GUTS) Key Stats
With a market capitalization of 141.05 million, the company has a total of 48,977K Shares Outstanding. Currently, annual sales are 90 K while annual income is -68,690 K. The company’s previous quarter sales were 0 K while its latest quarter income was -24,970 K.
